Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/27/2012US20120245130 Methods of Using Substituted Tetracycline Compounds to Modulate RNA
09/27/2012US20120245129 Use of s1p receptor modulator
09/27/2012US20120245128 Rapid detection and quantification of modification of medicinal compounds and drug resistance activity
09/27/2012US20120245127 Methods of Treating Cell Proliferative Disorders
09/27/2012US20120245125 Pyridazine compounds, compositions and methods
09/27/2012US20120245124 TRPV3 Modulators
09/27/2012US20120245123 Methods for improving bone health in infants using prebiotics
09/27/2012US20120245122 Carotenoid-containing compositions and methods
09/27/2012US20120245121 Methods for improving bone health in infants using long chain polyunsaturated fatty acids
09/27/2012US20120245120 Zinc sucrose octasulfates, their preparation, and pharmaceutical and cosmetic uses thereof
09/27/2012US20120245119 Method for separating sialyllactose material
09/27/2012US20120245118 Methods and compositions for alleviating stuttering
09/27/2012US20120245117 Methods of treating squamous cell lung cancer with 4-iodo-3-nitrobenzamide in combination with gemcitabine and carboplatin
09/27/2012US20120245116 Inhibiting GS-FDH to Modulate No Bioactivity
09/27/2012US20120245115 1-Methylnicotinaide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities
09/27/2012US20120245113 Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
09/27/2012US20120245112 Synthesis and identification of novel rsk-specific inhibitors
09/27/2012US20120245111 Flavanones-containing food compositions
09/27/2012US20120245110 Vascular leakage inhibitor
09/27/2012US20120245109 Antithrombotic dual inhibitors comprising a biotin residue
09/27/2012US20120245108 Method of modulating complement factor b (cfb) expression in cells
09/27/2012US20120245107 Methods of reducing the proliferation and viablility of microbial agents
09/27/2012US20120245089 Use of the sparc microenvironment signature in the treatment of cancer
09/27/2012US20120245087 Novel tissue protective erythropoietin receptor (nepor) and methods of use
09/27/2012US20120245080 Mineral salt-sulfonic acid compositions and methods of use
09/27/2012US20120245078 Means and methods for treating ischemic conditions
09/27/2012US20120245029 Novel phosph(on)ate- and sulf(on)ate-based phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
09/27/2012US20120244223 Orally dispersible tablet
09/27/2012US20120244222 Osmotic mediated release synthetic nanocarriers
09/27/2012US20120244221 Extended-release formulation for reducing the frequency of urination and method of use thereof
09/27/2012US20120244220 Atrovastatin-containing coated preparation
09/27/2012US20120244219 Stable benzimidazole formulation
09/27/2012US20120244218 Calcium supplement
09/27/2012US20120244217 4-methylpyrazole formulations
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244215 High-strength testosterone undecanoate compositions
09/27/2012US20120244214 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
09/27/2012US20120244212 Enhanced method and composition for the treatment of hiv+ tuberculosis patients with anti-retroviral drugs and liposomal encapsulation for delivery of reduced glutathione
09/27/2012US20120244211 Compositions And Methods For Treatment Of The Side-Effects Associated With Administration Of Cancer Chemotherapeutic Agents
09/27/2012US20120244210 Composition for suppressing expression of target gene
09/27/2012US20120244209 Tusc2 therapies
09/27/2012US20120244207 Methods For Increasing Efficacy of Lipid Formulated siRNA
09/27/2012US20120244206 Dual action, inhaled formulations providing both an immediate and sustained release profile
09/27/2012US20120244204 Composition for external use and method for producing the same
09/27/2012US20120244194 Pharmaceutical Compositions Comprising Terbinafine
09/27/2012US20120244193 Passive solid tumor targeting anticancer prodrug and preparation method thereof
09/27/2012US20120244185 Immunization strategy to prevent h1n1 infection
09/27/2012US20120244182 Use of tryptanthrin compounds for immune potentiation
09/27/2012US20120244172 Conjudates of Pyrrolo[1,4]Benzodiazepine Dimers As Anticancer Agents
09/27/2012US20120244171 Cytotoxic benzodiazepine derivatives
09/27/2012US20120244170 Treating cancer by modulating mex-3
09/27/2012US20120244160 Identification of modulators of serine protease inhibitor kazal and their use as anti-cancer and anti-viral agents
09/27/2012US20120244157 Use of tnf-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus
09/27/2012US20120244149 Benzoxazepin pi3k inhibitor compounds and methods of use
09/27/2012US20120244141 Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
09/27/2012US20120244134 Process for preparing aqueous dispersions containing high concentration of nano/submicron, hydrophobic, functional compounds
09/27/2012US20120244131 Method for modulating the efficiency of double-strand break-induced mutagenesis
09/27/2012US20120244121 Modulators of toll-like receptor 7
09/27/2012US20120244120 Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection
09/27/2012US20120244119 Anti-infective agents and uses thereof
09/27/2012US20120244110 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012US20120244108 Compositions And Methods For Separating Tissue
09/27/2012US20120244107 Biodegradable hydrogel
09/27/2012US20120244106 Use of the combination of teriflunomide and glatiramer acetate for treating multiple sclerosis
09/27/2012US20120244105 Pharmaceutical Compositions Comprising Polymeric Binders with Non-Hydrolysable Covalent Bonds and Their Use in Treating Celiac Disease
09/27/2012US20120244104 Nicotine containing formulation
09/27/2012US20120244103 Reversible oral adhesive gel
09/27/2012US20120244102 Agent for preventing or treating crohn's disease, comprising organic acid polymer
09/27/2012US20120244097 Reversely thermo-reversible hydrogel compositions
09/27/2012US20120244096 Plant extract, compositions containing same, method of extraction and uses thereof
09/27/2012US20120244095 Compositions containing polymeric, ionic compounds comprising imidazolium groups
09/27/2012US20120244084 Herbal extracts and flavor systems for oral products and methods of making the same
09/27/2012US20120244077 Methods and compositions for maintenance of a functional wound
09/27/2012CA2831027A1 Methods and compositions for the generation of peracetic acid on site at the point-of-use
09/27/2012CA2830987A1 Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine
09/27/2012CA2830933A1 Methods for treating or preventing urological inflammation
09/27/2012CA2830902A1 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
09/27/2012CA2830882A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
09/27/2012CA2830788A1 Methods and compositions for treatment of attention deficit disorder
09/27/2012CA2830780A1 Azole compounds as pim inhibitors
09/27/2012CA2830765A1 Solid preparation containing ambroxol
09/27/2012CA2830742A1 Opioid receptor ligands and methods of using and making same
09/27/2012CA2830616A1 Pharmaceutical composition for treating hepatic disease
09/27/2012CA2830540A1 Glucosylceramide synthase inhibitors
09/27/2012CA2830519A1 Myelin regeneration with androgens
09/27/2012CA2830516A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012CA2830515A1 6-substituted estradiol derivatives for use in remyelination of nerve axons
09/27/2012CA2830511A1 Pharmaceutical compositions comprising a water-insoluble antipsychotic and sorbitan esters
09/27/2012CA2830476A1 Compositions and methods useful for ameliorating age related maladies
09/27/2012CA2830458A1 Combinations of alpha 7 nicotinic acetylcholine receptor activators and mglur5 antagonists for use in dopamine induced dyskinesia in parkinson's disease
09/27/2012CA2830411A1 Pyrimidine cyclohexyl glucocorticoid receptor modulators
09/27/2012CA2830348A1 Piperidinone carboxamide spirohydantoin cgrp receptor antagonists
09/27/2012CA2830342A1 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
09/27/2012CA2830296A1 Method of screening antiretroviral compounds and vaccine
09/27/2012CA2830129A1 Novel pyrimidine derivatives
09/27/2012CA2830081A1 Treatment of solid tumours
09/27/2012CA2829794A1 Methods for improving bone health in infants using long chain polyunsaturated fatty acids
09/27/2012CA2829755A1 Treatment of proliferative disorders with a chemiluminescent agent
09/27/2012CA2829690A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same
09/27/2012CA2829687A1 New crystalline form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same
1 ... 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 ... 7860